2 news items
CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients
CASI
MRK
5 Mar 24
Price Action: CASI Pharmaceutical shares are up 6.39% at $5.41 on the last check Tuesday.
Illustration of lab worker created using artificial intelligence with MidJourney.
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
ABBV
LLY
MRK
15 Feb 24
connections with family, friends, and co-workers. None of the treatments that are now on the market is completely effective against the full range of pain
- Prev
- 1
- Next